US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
Patent 11701372 was granted and assigned to Gilead Sciences on July, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
